March 1, 2012: New ACTTION Initiative on Assessment of Abuse Liability
ACTTION is pleased to announce that it is launching an initiative to develop definitions, classification systems, and rating scales for evaluating abuse liability of analgesic medications.
This initiative ─ “Abuse Liability Evaluation for Research, Treatment, and Training” (ALERTT) ─ will be an ongoing effort focusing on approaches that can be used for evaluating misuse, abuse, diversion, and other evidence of abuse liability in patients with chronic pain. ALERTT will be closely modeled on the FDA-Columbia University effort that developed C-CASA and C-SSRS for evaluating suicidality in clinical trials.
News
ACTTION Guide to Clinical Trials of Pain Treatments
The ACTTION Guide to Clinical Trials of Pain Treatments consists of two supplements published in the journal Pain Reports that include a series of articles describing research designs and methods, study conduct, outcome measures, data analyses and interpretation, and reporting recommendations for clinical trials of acute and chronic pain treatments.
Part I includes 9 articles that can be found here, and Part II includes 6 articles that can be found here.